What is Aveanna Healthcare Holdings, Inc.'s earnings per share (EPS)?

Aveanna Healthcare Holdings, Inc. (AVAH) reported diluted earnings per share of $1.05 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Aveanna Healthcare Holdings, Inc. Financials

AVAH

FY2026 annual

Revenue $2.4B YoY not available

Net Income $225K YoY not available

EPS (Diluted) $1.05 YoY not available

Free Cash Flow Not reported for FY2026

Source SEC Filings (10-K/10-Q) Data as of Jul 4, 2026 Currency USD FYE January

Aveanna Healthcare Holdings, Inc. (AVAH) reported $2.4B in revenue for fiscal year 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AVAH FY2026 2026-08-13

Operating leverage has repaired liquidity, but interest-heavy financing still absorbs much of the profit this business now creates.

In the latest year, operating cash flow reached $125.9M and current ratio climbed above 1.0x, after earlier years below that threshold. Because long-term debt was still about $1.3B, the balance-sheet repair came from better cash conversion rather than meaningful deleveraging.

Revenue reached $2.4B while SG&A was only $374.5M, showing that added volume is not being matched by overhead dollar for dollar. Gross margin also edged up to 33.3%, so the margin step-up was not only back-office discipline; some improvement happened in the underlying service economics too.

Even after the operating rebound, interest expense of $140.1M absorbed more than half of operating income of $256.5M, which explains why net income stayed near break-even. Goodwill was $1.1B, so a large share of assets is acquisition value rather than liquid support, making the new positive equity base thinner than it first appears.

Financial Health Signals

Financial Health Score 37/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Aveanna Healthcare Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Aveanna Healthcare Holdings, Inc. has an operating margin of 10.5%, meaning the company retains $11 of operating profit per $100 of revenue. This results in a moderate score of 47/100, indicating healthy but not exceptional operating efficiency. This is up from 6.9% the prior year.

Growth

Aveanna Healthcare Holdings, Inc.'s revenue surged 20.2% year-over-year to $2.4B, reflecting rapid business expansion. This strong growth earns a score of 72/100.

Leverage

Aveanna Healthcare Holdings, Inc. has elevated debt relative to equity (D/E of 6.62), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 14/100, reflecting increased financial risk.

Liquidity

Aveanna Healthcare Holdings, Inc.'s current ratio of 1.32 indicates adequate short-term liquidity, earning a score of 34/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Not available for Aveanna Healthcare Holdings, Inc., and counted as zero in the overall score.

Returns

Aveanna Healthcare Holdings, Inc.'s ROE of 0.1% shows moderate profitability relative to equity, earning a score of 54/100.

Altman Z-Score Grey Zone

1.82

Aveanna Healthcare Holdings, Inc. scores 1.82, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($2.8B) relative to total liabilities ($1.8B). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Aveanna Healthcare Holdings, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

N/A

Aveanna Healthcare Holdings, Inc. reported $225K of net income while generating $125.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Interest Coverage At Risk

1.83x

Aveanna Healthcare Holdings, Inc. earns $1.83 in operating income for every $1 of interest expense ($256.5M vs $140.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.4B

5Y CAGR+10.2%

Aveanna Healthcare Holdings, Inc. generated $2.4B in revenue in fiscal year 2026.

EBITDA

$267.0M

5Y CAGR+81.5%

Aveanna Healthcare Holdings, Inc.'s EBITDA was $267.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income

$225K

Aveanna Healthcare Holdings, Inc. reported $225K in net income in fiscal year 2026.

EPS (Diluted)

$1.05

Aveanna Healthcare Holdings, Inc. earned $1.05 per diluted share (EPS) in fiscal year 2026.

Cash & Balance Sheet

Cash & Debt

$193.3M

5Y CAGR+7.1%

Aveanna Healthcare Holdings, Inc. held $193.3M in cash against $1.3B in long-term debt as of fiscal year 2026.

Shares Outstanding

211M

Aveanna Healthcare Holdings, Inc. had 211M shares outstanding in fiscal year 2026.

Free Cash Flow

Not reported for fiscal year 2026.

Dividends Per Share

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin

33.3%

5Y CAGR+2.9pp

Aveanna Healthcare Holdings, Inc.'s gross margin was 33.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs.

Operating Margin

10.5%

5Y CAGR+10.8pp

Aveanna Healthcare Holdings, Inc.'s operating margin was 10.5% in fiscal year 2026, reflecting core business profitability.

Net Margin

0.0%

5Y CAGR+3.8pp

Aveanna Healthcare Holdings, Inc.'s net profit margin was 0.0% in fiscal year 2026, showing the share of revenue converted to profit.

Return on Equity

0.1%

Aveanna Healthcare Holdings, Inc.'s ROE was 0.1% in fiscal year 2026, measuring profit generated per dollar of shareholder equity.

Capital Allocation

None of these metrics is reported for fiscal year 2026.

AVAH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AVAH annual income statement

Metric	TTM	FY26	FY24	FY23	FY22	FY22	FY21	FY19
Revenue	$2.6B	$2.4B	$2.0B+6.8%	$1.9B+6.0%	$1.8B	$1.7B+12.3%	$1.5B	$1.4B
Cost of Revenue	$1.8B	$1.6B	$1.4B+6.9%	$1.3B+5.3%	$1.2B	$1.1B+9.2%	$1.0B	$964.8M
Gross Profit	$840.1M	$810.5M	$635.5M+6.7%	$595.4M+7.6%	$553.2M	$542.4M+19.3%	$454.5M	$419.3M
SG&A Expenses	$385.9M	$374.5M	$352.8M-2.3%	$361.0M+1.0%	$357.2M	$297.4M+23.4%	$240.9M	$227.8M
Operating Income	$273.9M	$256.5M	$139.8M+1631.8%	$8.1M+101.3%	-$642.3M	-$36.1M-935.6%	-$3.5M	$39.0M
Interest Expense	$124.7M	$140.1M	$156.6M+2.2%	$153.2M+42.3%	$107.7M	$68.9M-16.9%	$83.0M	$92.3M
Income Tax	-$120.7M	-$118.1M	$16.0M+457.8%	-$4.5M-151.2%	-$1.8M	$3.5M-34.8%	$5.3M	$1.5M
Net Income	$50.0M	$225K	-$11K+91.9%	-$135K+100.0%	-$662.0M	-$117.0M-105.2%	-$57.0M	-$76.5M
EPS (Diluted)	—	$1.05	-$0.06+91.5%	-$0.71	-$3.57	-$0.69	N/A	N/A

Metric	Q2'27	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25
Revenue	$670.5M+3.5%	$647.9M-2.2%	$662.5M+6.5%	$621.9M+5.5%	$589.6M+5.4%	$559.2M+7.6%	$519.9M+2.1%	$509.0M
Cost of Revenue	$452.0M+2.1%	$442.5M-1.5%	$449.2M+7.2%	$419.1M+10.7%	$378.8M+0.8%	$375.7M+7.9%	$348.1M-0.3%	$349.3M
Gross Profit	$218.5M+6.4%	$205.4M-3.7%	$213.3M+5.2%	$202.8M-3.8%	$210.8M+14.8%	$183.6M+6.9%	$171.7M+7.5%	$159.7M
SG&A Expenses	$97.1M+1.3%	$95.8M-1.9%	$97.6M+2.4%	$95.4M+5.9%	$90.1M-1.4%	$91.4M+3.0%	$88.7M+0.6%	$88.2M
Operating Income	$80.0M+15.4%	$69.3M-2.4%	$71.0M+32.6%	$53.6M-33.0%	$80.0M+54.5%	$51.8M+13.2%	$45.8M+34.5%	$34.0M
Interest Expense	$27.8M-4.7%	$29.2M-10.6%	$32.6M-7.1%	$35.1M-2.4%	$36.0M-0.9%	$36.3M-4.6%	$38.1M-2.9%	$39.2M
Income Tax	$16.2M+387.1%	$3.3M+102.4%	-$139.5M-21462.1%	-$647K-103.8%	$17.1M+245.4%	$5.0M+320.7%	-$2.2M-114.5%	$15.5M
Net Income	$40.3M-3.3%	$41.7M+190.4%	-$46.1M-427.5%	$14.1M-48.0%	$27.0M+420.4%	$5.2M-87.0%	$40.1M+193.6%	-$42.8M
EPS (Diluted)	$0.18-5.3%	$0.19	N/A	$0.06-53.8%	$0.13+333.3%	$0.03	N/A	-$0.22

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q3 FY2026 through Q2 FY2027, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

No annual filing on record for: FY2020, FY2025.

AVAH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AVAH annual balance sheet

Metric	FY26	FY24	FY23	FY22	FY22	FY21	FY19
Total Assets	$2.0B	$1.7B+3.1%	$1.6B-5.8%	$1.7B	$2.3B+26.6%	$1.8B	N/A
Current Assets	$560.2M	$392.7M+24.7%	$314.9M+16.7%	$269.8M	$279.2M-18.0%	$340.6M	N/A
Cash & Equivalents	$193.3M	$84.3M+91.8%	$43.9M+128.7%	$19.2M	$30.5M-77.8%	$137.3M	N/A
Accounts Receivable	$313.4M	$265.2M+12.1%	$236.6M+6.9%	$221.2M	$218.9M+26.6%	$172.9M	N/A
Goodwill	$1.1B	$1.1B0.0%	$1.1B-9.1%	$1.2B	$1.8B+39.4%	$1.3B	$1.2B
Total Liabilities	$1.8B	$1.8B+2.6%	$1.7B+1.4%	$1.7B	$1.7B+7.6%	$1.6B	N/A
Current Liabilities	$424.5M	$402.2M+13.4%	$354.8M+8.7%	$326.5M	$344.8M+32.4%	$260.4M	N/A
Long-Term Debt	$1.3B	$1.3B-0.4%	$1.3B-0.4%	$1.3B	$1.2B+5.4%	$1.2B	N/A
Total Equity	$194.5M	-$123.6M+4.6%	-$129.6M-1953.4%	-$6.3M	$635.8M+139.9%	$265.0M	$270.2M
Retained Earnings	-$1.2B	-$1.4B-0.8%	-$1.4B-10.9%	-$1.2B	-$574.7M-25.6%	-$457.6M	N/A

Metric	Q2'27	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25
Total Assets	$2.1B+4.2%	$2.0B+0.5%	$2.0B+11.2%	$1.8B+2.2%	$1.8B+6.6%	$1.7B-0.2%	$1.7B+1.2%	$1.6B
Current Assets	$478.1M-16.9%	$575.3M+2.7%	$560.2M+11.5%	$502.6M+11.7%	$449.9M+10.4%	$407.6M+3.8%	$392.7M+3.0%	$381.4M
Cash & Equivalents	$97.2M-48.6%	$189.3M-2.1%	$193.3M+32.5%	$145.9M+44.8%	$100.7M+40.9%	$71.5M-15.2%	$84.3M+7.4%	$78.5M
Accounts Receivable	$337.2M+1.4%	$332.7M+6.2%	$313.4M+0.2%	$312.8M-1.1%	$316.3M+7.3%	$294.8M+11.2%	$265.2M-0.1%	$265.4M
Goodwill	$1.3B+13.8%	$1.1B0.0%	$1.1B+0.4%	$1.1B-0.2%	$1.1B+6.1%	$1.1B0.0%	$1.1B0.0%	$1.1B
Total Liabilities	$1.8B+2.1%	$1.8B-2.0%	$1.8B+0.9%	$1.8B+1.0%	$1.8B+1.3%	$1.8B-1.5%	$1.8B-0.8%	$1.8B
Current Liabilities	$411.3M+5.4%	$390.4M-8.0%	$424.5M+3.6%	$409.7M-1.1%	$414.2M+6.7%	$388.3M-3.4%	$402.2M-1.0%	$406.0M
Long-Term Debt	$1.3B+0.1%	$1.3B-0.2%	$1.3B-0.2%	$1.3B+1.6%	$1.3B-0.1%	$1.3B-0.1%	$1.3B-0.3%	$1.3B
Total Equity	$287.3M+19.7%	$240.1M+23.4%	$194.5M+2017.4%	$9.2M+176.6%	-$12.0M+88.0%	-$100.1M+19.0%	-$123.6M+21.0%	-$156.4M
Retained Earnings	-$1.1B+3.6%	-$1.1B+3.6%	-$1.2B+13.4%	-$1.3B+1.0%	-$1.3B+2.0%	-$1.4B+0.4%	-$1.4B+2.1%	-$1.4B

Not reported in any period shown, so not listed: Inventory.

No annual filing on record for: FY2020, FY2025.

AVAH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AVAH annual cash flow statement

Metric	TTM	FY26	FY24	FY23	FY22	FY22	FY21	FY19
Operating Cash Flow	$168.2M	$125.9M	$32.6M+44.0%	$22.7M+146.8%	-$48.4M	-$11.3M-109.7%	$116.6M	-$8.7M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$15.9M+4.7%	$15.2M	$16.6M
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$27.3M-126.9%	$101.4M	-$25.4M
Investing Cash Flow	-$183.9M	-$22.3M	-$6.3M+28.1%	-$8.8M+65.2%	-$25.3M	-$681.8M-252.3%	-$193.5M	-$17.8M
Financing Cash Flow	$12.2M	$5.4M	$14.0M+29.3%	$10.8M-82.6%	$62.4M	$586.3M+178.0%	$210.9M	$21.9M

Metric	Q2'27	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25
Operating Cash Flow	$80.9M+1760.8%	$4.3M-91.3%	$49.7M+49.8%	$33.2M-35.6%	$51.6M+697.4%	-$8.6M-164.4%	$13.4M-54.4%	$29.4M
Investing Cash Flow	-$175.4M-3748.3%	-$4.6M-133.8%	-$1.9M+3.5%	-$2.0M+87.4%	-$16.0M-580.7%	-$2.3M-53.6%	-$1.5M+30.9%	-$2.2M
Financing Cash Flow	$2.4M+162.5%	-$3.8M-902.1%	-$377K-102.7%	$13.9M+319.9%	-$6.3M-249.7%	-$1.8M+70.0%	-$6.1M-267.2%	$3.6M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

No annual filing on record for: FY2020, FY2025.

AVAH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

AVAH annual financial ratios

Metric	FY26	FY24	FY23	FY22	FY22	FY21	FY19
Gross Margin	33.3%	31.4%0.0pp	31.4%+0.5pp	30.9%	32.3%+1.9pp	30.4%	30.3%
Operating Margin	10.5%	6.9%+6.5pp	0.4%+36.4pp	-35.9%	-2.1%-1.9pp	-0.2%	2.8%
Net Margin	0.0%	0.0%0.0pp	0.0%+37.0pp	-37.0%	-7.0%-3.1pp	-3.8%	-5.5%
Return on Equity	0.1%	N/A	N/A	N/A	-18.4%+3.1pp	-21.5%	-28.3%
Return on Assets	0.0%	0.0%0.0pp	0.0%+38.7pp	-38.7%	-5.0%-1.9pp	-3.1%	N/A
Current Ratio	1.32	0.98+0.1x	0.89+0.1x	0.83	0.81-0.5x	1.31	N/A
Debt-to-Equity	6.62	N/A	N/A	N/A	1.93-2.5x	4.39	N/A
FCF Margin	N/A	N/A	N/A	N/A	-1.6%-8.4pp	6.8%	-1.8%

Metric	Q2'27	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25
Gross Margin	32.6%+0.9pp	31.7%-0.5pp	32.2%-0.4pp	32.6%-3.1pp	35.8%+2.9pp	32.8%-0.2pp	33.0%+1.7pp	31.4%
Operating Margin	11.9%+1.2pp	10.7%0.0pp	10.7%+2.1pp	8.6%-5.0pp	13.6%+4.3pp	9.3%+0.5pp	8.8%+2.1pp	6.7%
Net Margin	6.0%-0.4pp	6.4%+13.4pp	-7.0%-9.2pp	2.3%-2.3pp	4.6%+3.7pp	0.9%-6.8pp	7.7%+16.1pp	-8.4%
Return on Equity	14.0%-3.3pp	17.3%+41.0pp	-23.7%-176.8pp	153.1%	N/A	N/A	N/A	N/A
Return on Assets	1.9%-0.2pp	2.1%+4.3pp	-2.3%-3.1pp	0.8%-0.8pp	1.5%+1.2pp	0.3%-2.1pp	2.4%+5.0pp	-2.6%
Current Ratio	1.16-0.3x	1.47+0.2x	1.32+0.1x	1.23+0.1x	1.090.0x	1.05+0.1x	0.980.0x	0.94
Debt-to-Equity	4.47-0.9x	5.35-1.3x	6.62-133.8x	140.39	N/A	N/A	N/A	N/A

No annual filing on record for: FY2020, FY2025.

Similar Companies

National Health NHC

$3.6B

Ardent Health ARDT

$1.5B

Brookdale Sr Living Inc BKD

$2.9B

P3 HEALTH PARTNERS INC PIII

$41.3M

Select Medical SEM

$2.0B

Where Aveanna Healthcare Holdings, Inc. Ranks

Frequently Asked Questions

What is Aveanna Healthcare Holdings, Inc.'s annual revenue?

Aveanna Healthcare Holdings, Inc. (AVAH) reported $2.4B in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Aveanna Healthcare Holdings, Inc. profitable?

Yes, Aveanna Healthcare Holdings, Inc. (AVAH) reported a net income of $225K in fiscal year 2026, with a net profit margin of 0.0%.

What is Aveanna Healthcare Holdings, Inc.'s EBITDA?

Aveanna Healthcare Holdings, Inc. (AVAH) had EBITDA of $267.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Aveanna Healthcare Holdings, Inc. have?

As of fiscal year 2026, Aveanna Healthcare Holdings, Inc. (AVAH) had $193.3M in cash and equivalents against $1.3B in long-term debt.

What is Aveanna Healthcare Holdings, Inc.'s gross margin?

Aveanna Healthcare Holdings, Inc. (AVAH) had a gross margin of 33.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Aveanna Healthcare Holdings, Inc.'s operating margin?

Aveanna Healthcare Holdings, Inc. (AVAH) had an operating margin of 10.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Aveanna Healthcare Holdings, Inc.'s net profit margin?

Aveanna Healthcare Holdings, Inc. (AVAH) had a net profit margin of 0.0% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Aveanna Healthcare Holdings, Inc.'s return on equity (ROE)?

Aveanna Healthcare Holdings, Inc. (AVAH) has a return on equity of 0.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Aveanna Healthcare Holdings, Inc.'s operating cash flow?

Aveanna Healthcare Holdings, Inc. (AVAH) generated $125.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Aveanna Healthcare Holdings, Inc.'s total assets?

Aveanna Healthcare Holdings, Inc. (AVAH) had $2.0B in total assets as of fiscal year 2026, including both current and long-term assets.

How many shares does Aveanna Healthcare Holdings, Inc. have outstanding?

Aveanna Healthcare Holdings, Inc. (AVAH) had 211M shares outstanding as of fiscal year 2026.

What is Aveanna Healthcare Holdings, Inc.'s current ratio?

Aveanna Healthcare Holdings, Inc. (AVAH) had a current ratio of 1.32 as of fiscal year 2026, which is considered adequate.

What is Aveanna Healthcare Holdings, Inc.'s debt-to-equity ratio?

Aveanna Healthcare Holdings, Inc. (AVAH) had a debt-to-equity ratio of 6.62 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Aveanna Healthcare Holdings, Inc.'s return on assets (ROA)?

Aveanna Healthcare Holdings, Inc. (AVAH) had a return on assets of 0.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Aveanna Healthcare Holdings, Inc.'s Altman Z-Score?

Aveanna Healthcare Holdings, Inc. (AVAH) has an Altman Z-Score of 1.82, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Aveanna Healthcare Holdings, Inc.'s Piotroski F-Score?

Aveanna Healthcare Holdings, Inc. (AVAH) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Aveanna Healthcare Holdings, Inc.'s earnings high quality?

Aveanna Healthcare Holdings, Inc. (AVAH) reported $225K of net income while generating $125.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Aveanna Healthcare Holdings, Inc. cover its interest payments?

Aveanna Healthcare Holdings, Inc. (AVAH) has an interest coverage ratio of 1.83x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Aveanna Healthcare Holdings, Inc.?

Aveanna Healthcare Holdings, Inc. (AVAH) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.